Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor

[1]  E. Merritt,et al.  The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites , 2014, Parasitology.

[2]  Dustin J Maly,et al.  Bumped Kinase Inhibitor 1294 Treats Established Toxoplasma gondii Infection , 2014, Antimicrobial Agents and Chemotherapy.

[3]  Dustin J Maly,et al.  A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation. , 2014, The Journal of infectious diseases.

[4]  Dustin J Maly,et al.  A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis. , 2013, The Journal of infectious diseases.

[5]  D. Knowles,et al.  Lymphocytes and Macrophages Are Infected by Theileria equi, but T Cells and B Cells Are Not Required to Establish Infection In Vivo , 2013, PloS one.

[6]  J. Le bras,et al.  Plasmodium falciparum Polymorphisms Associated with Ex Vivo Drug Susceptibility and Clinical Effectiveness of Artemisinin-Based Combination Therapies in Benin , 2013, Antimicrobial Agents and Chemotherapy.

[7]  D. Knowles,et al.  Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses. , 2013, Veterinary journal.

[8]  B. Soto‐Blanco,et al.  Detection of Theileria equi in spleen and blood of asymptomatic piroplasm carrier horses , 2013, Acta Parasitologica.

[9]  D. Aubert,et al.  Induction of sulfadiazine resistance in vitro in Toxoplasma gondii. , 2013, Experimental parasitology.

[10]  I. Igarashi,et al.  Evaluation of in vitro and in vivo inhibitory effects of fusidic acid on Babesia and Theileria parasites. , 2013, Veterinary parasitology.

[11]  Joana C. Silva,et al.  Comparative genomic analysis and phylogenetic position of Theileria equi , 2012, BMC Genomics.

[12]  I. Igarashi,et al.  Inhibitory effects of pepstatin A and mefloquine on the growth of Babesia parasites. , 2012, The American journal of tropical medicine and hygiene.

[13]  S. White,et al.  Re-Emergence of the Apicomplexan Theileria equi in the United States: Elimination of Persistent Infection and Transmission Risk , 2012, PloS one.

[14]  Steven M. Johnson,et al.  Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors. , 2012, The Journal of clinical investigation.

[15]  S. White,et al.  In vitro activity of ponazuril against Theileria equi. , 2012, Veterinary parasitology.

[16]  Steven M. Johnson,et al.  Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1. , 2012, Journal of medicinal chemistry.

[17]  Steven M. Johnson,et al.  Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity. , 2012, Journal of medicinal chemistry.

[18]  D. Knowles,et al.  Equine Piroplasmosis Associated with Amblyomma cajennense Ticks, Texas, USA , 2011, Emerging infectious diseases.

[19]  Xavier C Ding,et al.  Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets. , 2011, Trends in parasitology.

[20]  Dustin J Maly,et al.  Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii , 2010 .

[21]  M. Takiguchi,et al.  Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro. , 2010, The Journal of veterinary medical science.

[22]  Kazuya Nakamura,et al.  Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites. , 2010, Veterinary parasitology.

[23]  G. Crescenzo,et al.  Pharmacokinetics of imidocarb dipropionate in horses after intramuscular administration. , 2010, Equine veterinary journal.

[24]  Xiubo Li,et al.  Residue depletion of imidocarb in Swine tissue. , 2009, Journal of agricultural and food chemistry.

[25]  N. Day,et al.  Plasmodium falciparum pfmdr1 Amplification, Mefloquine Resistance, and Parasite Fitness , 2009, Antimicrobial Agents and Chemotherapy.

[26]  J. Coetzee,et al.  Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures. , 2006, Journal of veterinary pharmacology and therapeutics.

[27]  J. Frangos,et al.  Plasmodium berghei Resists Killing by Reactive Oxygen Species , 2005, Infection and Immunity.

[28]  D. Knowles,et al.  Ability of the Vector Tick Boophilus microplus To Acquire and Transmit Babesia equi following Feeding on Chronically Infected Horses with Low-Level Parasitemia , 2005, Journal of Clinical Microbiology.

[29]  V. Naidoo,et al.  Identification of anti-babesial activity for four ethnoveterinary plants in vitro. , 2005, Veterinary parasitology.

[30]  O. Martins-Filho,et al.  Molecular fluorescent approach to assessing intraerythrocytic hemoprotozoan Babesia canis infection in dogs. , 2004, Veterinary parasitology.

[31]  K. Wilschut,et al.  An amino acid substitution in the Babesia bovis dihydrofolate reductase-thymidylate synthase gene is correlated to cross-resistance against pyrimethamine and WR99210. , 2004, Molecular and biochemical parasitology.

[32]  K. Fujisaki,et al.  Growth inhibitory effect of triclosan on equine and bovine Babesia parasites. , 2003, The American journal of tropical medicine and hygiene.

[33]  K. Fujisaki,et al.  Growth-Inhibitory Effects of Artesunate, Pyrimethamine, and Pamaquine against Babesia equi and Babesia caballi in In Vitro Cultures , 2003, Antimicrobial Agents and Chemotherapy.

[34]  G. Crescenzo,et al.  Depletion and bioavailability of imidocarb residues in sheep and goat tissues. , 2002, Veterinary and human toxicology.

[35]  N. Ikuta,et al.  Detection of Babesia equi (Laveran, 1901) by nested polymerase chain reaction. , 2001, Veterinary parasitology.

[36]  F. Ferreira,et al.  Control of equine piroplasmosis in Brazil. , 1999, The Onderstepoort journal of veterinary research.

[37]  N. Kapel,et al.  In Vitro Evaluation of Drug Susceptibilities of Babesia divergens Isolates , 1998, Antimicrobial Agents and Chemotherapy.

[38]  S. Okuda,et al.  Detection of canine erythrocytes infected with Babesia gibsoni by flow cytometry. , 1996, The Journal of parasitology.

[39]  D. Knowles.  Control of Babesia equi parasitemia. , 1996, Parasitology today.

[40]  A. Trees,et al.  In vitro responsiveness of Babesia bovis to imidocarb dipropionate and the selection of a drug-adapted line. , 1996, Veterinary parasitology.

[41]  B. Lake,et al.  Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[42]  W. Frerichs,et al.  Babesia equi erythrocytic stage continuously cultured in an enriched medium. , 1994, The Journal of parasitology.

[43]  D. Knowles,et al.  Detection of equine antibody to Babesia equi merozoite proteins by a monoclonal antibody-based competitive inhibition enzyme-linked immunosorbent assay , 1991, Journal of clinical microbiology.

[44]  R. Harrington,et al.  A monoclonal antibody defines a geographically conserved surface protein epitope of Babesia equi merozoites , 1991, Infection and immunity.

[45]  Zaugg Jl,et al.  Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids , 1987 .

[46]  Camp Bj,et al.  Absorption, distribution, and excretion of imidocarb dipropionate in sheep. , 1977 .

[47]  N. Stewart,et al.  Tolerance to imidocarb induced experimentally in tick-transmitted Babesia argentina. , 1977, Australian veterinary journal.

[48]  W. Frerichs,et al.  Equine piroplasmosis (Babesia equi): therapeutic trials of imidocarb dihydrochloride in horses and donkeys , 1973, Veterinary Record.

[49]  Holbrook Aa.  Biology of equine piroplasmosis. , 1969 .

[50]  I. Igarashi,et al.  Inhibitory effect of allicin on the growth of Babesia and Theileria equi parasites , 2013, Parasitology Research.

[51]  陳怡伶,et al.  The therapeutic efficacy of two antibabesial strategies against Babesia gibsoni. , 2012 .

[52]  A. Birkenheuer,et al.  Efficacy of atovaquone and azithromycin or imidocarb dipropionate in cats with acute cytauxzoonosis. , 2011, Journal of veterinary internal medicine.

[53]  Dustin J Maly,et al.  Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondii. , 2010, ACS medicinal chemistry letters.

[54]  W. Davis,et al.  A rapid, reliable method of evaluating growth and viability of intraerythrocytic protozoan hemoparasites using fluorescence flow cytometry. , 1992, Memorias do Instituto Oswaldo Cruz.

[55]  K. Kuttler,et al.  Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids. , 1987, American journal of veterinary research.

[56]  R. H. Davis,et al.  Absorption, distribution, and excretion of imidocarb dipropionate in sheep. , 1977, American journal of veterinary research.

[57]  A. A. Holbrook.  Biology of equine piroplasmosis. , 1969, Journal of the American Veterinary Medical Association.